New cell therapy tested for leukemia patients out of options
NCT ID NCT07246707
Summary
This is the first human study to test the safety and early effects of an experimental cell therapy called KSV01. It's for adults aged 18-80 whose B-cell acute lymphoblastic leukemia has come back or hasn't responded to standard treatments. The main goal is to find a safe dose by giving the treatment to small groups of patients at increasing levels.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for B ALL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
First Affiliated Hospital of Zhejiang University
RECRUITINGHangzhou, China
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.